"Leukemia, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
| Descriptor ID |
D015458
|
| MeSH Number(s) |
C04.557.337.428.580 C15.604.515.560.575 C20.683.515.528.582
|
| Concept/Terms |
Leukemia, T-Cell- Leukemia, T-Cell
- Leukemia, T Cell
- Leukemia, Lymphocytic, T-Cell
- Lymphocytic Leukemia, T-Cell
- Leukemia, T-Cell Lymphocytic
- Leukemias, T-Cell Lymphocytic
- Lymphocytic Leukemia, T Cell
- Lymphocytic Leukemias, T-Cell
- T-Cell Lymphocytic Leukemia
- T-Cell Lymphocytic Leukemias
- T-Cell Leukemia
- Leukemias, T-Cell
- T Cell Leukemia
- T-Cell Leukemias
- T-Lymphocytic Leukemia
- Leukemia, T-Lymphocytic
- Leukemias, T-Lymphocytic
- T-Lymphocytic Leukemias
- Leukemia, Lymphocytic, T Cell
- T Lymphocytic Leukemia
- Leukemia, T Lymphocytic
- Leukemias, T Lymphocytic
- Lymphocytic Leukemia, T
- Lymphocytic Leukemias, T
- T Lymphocytic Leukemias
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, T-Cell".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, T-Cell".
This graph shows the total number of publications written about "Leukemia, T-Cell" by people in this website by year, and whether "Leukemia, T-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 2 | 3 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, T-Cell" by people in Profiles.
-
Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemia. Blood Cancer Discov. 2020 09; 1(2):178-197.
-
A population-based analysis of second primary malignancies in T-cell neoplasms. Br J Haematol. 2019 04; 185(2):338-342.
-
Insulin receptor substrate 1 is a substrate of the Pim protein kinases. Oncotarget. 2016 Apr 12; 7(15):20152-65.
-
PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers. Cancer Discov. 2015 Mar; 5(3):288-303.
-
Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia. Pediatr Blood Cancer. 2014 Dec; 61(12):2230-5.
-
Cell cycle-specific function of Ikaros in human leukemia. Pediatr Blood Cancer. 2012 Jul 15; 59(1):69-76.
-
Tumor suppression in T cell leukemia--the role of Ikaros. Leuk Res. 2010 Apr; 34(4):416-7.
-
Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. Mol Cancer Res. 2006 Aug; 4(8):549-62.
-
Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in Delta9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells. Leuk Res. 2005 Aug; 29(8):915-22.
-
The cyclin D3 knockout: a pound of redundancy with a dash of tissue specificity. Cancer Biol Ther. 2004 Feb; 3(2):162-4.